AstraZeneca and Injectable Weight Loss Medication: An Informational Overview

AstraZeneca has a broad and established presence in metabolic health — particularly through its diabetes portfolio — but the two injectable medicines most commonly prescribed for weight management today sit outside its product range. The medicines people are most frequently prescribed for weight loss via injection are tirzepatide (brand name Mounjaro, developed by Eli Lilly) and semaglutide (brand name Wegovy, developed by Novo Nordisk). Both are prescription-only, once-weekly injectable treatments that act on appetite-regulating pathways in the body.

AstraZeneca does manufacture injectable medicines used in type 2 diabetes management, and research into cardiometabolic conditions is an active area across the pharmaceutical industry. However, if your prescriber has started you on an injectable weight loss medicine, it is most likely one of the two options above rather than an AstraZeneca product.

What makes injectable weight loss medicines distinct?

Injectable weight loss medicines approved for that specific indication work differently from older oral treatments. The GLP-1 class (and in the case of tirzepatide, the dual GIP/GLP-1 class) acts on appetite-regulating signals, commonly leading to a reduced sense of hunger and increased feelings of fullness. These are prescription-only treatments — suitability, dose, and duration are decisions made entirely by your prescriber or doctor, based on your individual health profile.

For a broader look at how these medicines fit into the wider category, the weight loss medication injection guide covers the main options in more detail. You can also explore the injectable weight loss overview for context on how this class of treatment is generally used. If you are curious about how injectable options compare with tablet-based alternatives, the page on non-injectable weight loss drugs is worth reading alongside this one.

Whichever injectable weight loss medicine you have been prescribed, staying consistent with your injections is one of the most important parts of the journey — and that starts with knowing exactly when you last injected, where you injected, and what dose you used.

GLP Trackr's injection-site tracking and rotation feature is built precisely for this. Each time you inject, you log the site (abdomen, thigh, or upper arm) and the app tracks your rotation history, suggesting where to inject next. Rotating sites matters because repeated injections in the same spot can affect how the medicine absorbs, and it is easy to lose track without a record. Alongside site tracking, dose logging means every injection is timestamped — so you always know where you are in your weekly schedule.

Dose reminders add another layer of consistency: a gentle prompt means a dose is far less likely to slip your mind during a busy week. Taken together, these tools turn what can feel like a lot to manage into a simple, reliable routine.

For a full guide to injectable weight loss medicines and how to get the most from your treatment, visit the weight loss injections hub.

Any questions about your specific medicine, your injection technique, or whether your treatment is right for you should always go to your prescriber or doctor — they have your full medical history and are best placed to advise. GLP Trackr helps you keep an accurate record to bring to those conversations; it is not a substitute for their guidance.

Ready to keep every injection organised? Download GLP Trackr on the App Store or Google Play and start your free 7-day trial — your injection history, site rotation, and weekly schedule all in one place.